Trial Profile
Clinical Trials Insight: 700040454
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2009
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Research & Development
- 13 Jan 2009 New trial record.